We are leaders in transgenics
, gene targeting
and CRISPR/Cas-mediated mutagenesis
in mice. We can design and validate your CRISPR/Cas targeting strategy, and generate mutant mice quickly.
are low, our wait times
are short and our success rates
are high. New transgenic and targeted mice that we have created are featured in over 200 publications
The Case Transgenic and Targeting Facility is supported by the Case Western Reserve University School of Medicine
the Case Comprehensive Cancer Center
and the Clinical and Translational Science Collaborative
, which has a pilot project grant program for our services, including CRISPR/Cas mutagenesis.